Physician

Mark A Kroll, MD

According to 2025 Medicare claims, Mark Kroll, MD (NPI: 1568494136) practices ophthalmology in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Montgomery, TN. This provider's primary affiliated billing organization is CLARKSVILLE OPHTHALMOLOGY P.C. (NPI: 1598746794; TIN: 620906808) and primary practice location at 37040-5243. Kroll is affiliated with the Connected Care of Middle Tennessee, LLC (ACO ID: A3840), participating under the MSSP model.

Kroll's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 391 traditional Medicare patients, billed 1,705 HCPCS/CPT codes, and received $256,959 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 463 prescription claims across 154 beneficiaries totaling $30,574 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). 2023 DME data shows 27 claims. Open Payments data shows 22 records totaling $482. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $416,621 to $256,959. Similarly, Part D prescription costs have fallen sharply in recent years, from $345,135 to $30,574. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,575	3,819	$416,621
2016	1,711	9,303	$621,735
2017	1,571	13,188	$637,994
2018	1,559	11,546	$591,431
2019	1,478	10,433	$576,380
2020	946	6,346	$286,756
2021	867	7,653	$346,420
2022	498	4,405	$259,870
2023	440	3,243	$235,596
2024	391	1,705	$256,959

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	743	2,835	$345,135
2016	731	2,591	$242,628
2017	581	2,930	$251,911
2018	607	3,018	$287,836
2019	610	2,953	$307,450
2020	479	2,523	$297,558
2021	444	2,161	$300,306
2022	276	996	$159,010
2023	157	389	$52,620
2024	154	463	$30,574

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	16	16	$819
2016	152	153	$9,360
2017	230	232	$13,544
2018	211	212	$12,393
2019	116	116	$7,641
2020	33	33	$1,620
2021	49	49	$3,716
2022	13	13	$853
2023	27	27	$2,386
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	267	493	$352
66821	Removal of recurring cataract in lens capsule using a laser	90	136	$222
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	173	173	$101
92136	Measurement of corneal curvature and depth of eye	266	322	$24
68841	Insertion of drug delivery implant into tear duct of eye	61	113	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Bromfenac Sodium	Bromfenac Sodium	40	1,086	$4,891
Lumigan	Bimatoprost	12	522	$4,382
Moxifloxacin	Moxifloxacin Hcl	121	2,239	$4,144
Prednisolone Acetate	Prednisolone Acetate	149	3,373	$3,473
Ketorolac Tromethamine	Ketorolac Tromethamine	72	1,551	$1,769

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$482	BIOTISSUE HOLDINGS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark A. Kroll, MD?

Tedicare shows public-source Medicare data for Mark A. Kroll, MD (NPI 1568494136), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark A. Kroll, MD have ACO affiliation data?

Mark A. Kroll, MD is shown with ACO affiliation data for Connected Care of Middle Tennessee, LLC (MSSP, ACO ID A3840).

What billing organization is linked to Mark A. Kroll, MD?

Mark A. Kroll, MD is linked to CLARKSVILLE OPHTHALMOLOGY P.C. (billing NPI 1598746794) in the available physician profile data.

Does Mark A. Kroll, MD have Open Payments data?

Mark A. Kroll, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.